Holen Sie sich die Stockscreener-App
4.01
5.87%
-0.25
Handel nachbörslich:
4.04
0.03
+0.75%
Larimar Therapeutics Inc Aktie (LRMR) Neueste Nachrichten
JMP Securities Lowers Price Target for Larimar Therapeutics (LRMR) | LRMR Stock News - GuruFocus
RSI Crosses Above 30 for Larimar Therapeutics Inc. — Reversal in SightJuly 2025 Macro Moves & High Accuracy Buy Signal Tips - sundaytimes.kr
Top Analysts Pick 3 Stocks with 300% Upside Potential - AInvest
Larimar Therapeutics stock price target lowered to $18 at JMP By Investing.com - Investing.com Canada
Larimar Therapeutics Aligns with FDA Guidance, Revises Nomlabofusp Submission Timeline - MSN
Larimar Therapeutics Advances Nomlabofusp Program Amid Financial Losses - TipRanks
Larimar: Q2 Earnings Snapshot - Chron
Larimar Therapeutics Receives Buy Rating from Citi with $12 Price Target - AInvest
Larimar Therapeutics stock holds Buy rating at Truist ahead of September data - Investing.com Canada
Larimar Therapeutics stock maintains Buy rating at Guggenheim ahead of key data - Investing.com Canada
Larimar Therapeutics Reports Q2 2025 Financial Results - TipRanks
Larimar Therapeutics: Operational Efficiency Gains Signal Resilience in a High-Risk Biotech Play - AInvest
Larimar Beats Q2 Loss Estimates - The Motley Fool
Larimar Beats Q2 Loss Estimates - Nasdaq
Larimar Therapeutics Reports Second Quarter 2025 Financial Results | LRMR Stock News - GuruFocus
Larimar Therapeutics Reports Second Quarter 2025 Financial Results - GlobeNewswire
Larimar Therapeutics prices $60M stock offering - MSN
Visual trend scoring systems applied to Larimar Therapeutics Inc.Dollar Strength & Entry and Exit Point Strategies - Newser
Analyzing net buyer seller activity in Larimar Therapeutics Inc.Short Setup & Long Hold Capital Preservation Plans - Newser
What are Larimar Therapeutics Inc.’s recent SEC filings showingBest Small Caps with Big Returns - classian.co.kr
Will Larimar Therapeutics Inc. stock recover after earnings300% Return Stock Forecast - thegnnews.com
Will Larimar Therapeutics Inc. benefit from rising consumer demandTop Earnings Growth Momentum Picks - newsyoung.net
Larimar Therapeutics: Institutional Confidence and Capital-Raising Strategy Signal Conviction in Long-Term Pipeline - AInvest
Institutional Investors Hold 40% Stake in Larimar Therapeutics - AInvest
With 40% stake, Larimar Therapeutics, Inc. (NASDAQ:LRMR) seems to have captured institutional investors' interest - Yahoo Finance
Larimar Therapeutics Insider Bought Shares Worth $30,000,000, According to a Recent SEC Filing - 富途牛牛
Larimar Therapeutics Sees Significant Stock Purchase by Director - AInvest
Larimar Therapeutics Stock (LRMR) Opinions on Public Offering Announcement - Quiver Quantitative
Mintz Advises on Larimar Therapeutics’ $69 Million Public Offering - Mintz
Larimar therapeutics: Deerfield funds buy $10.8m in shares - Investing.com India
Massive Stock Purchase by Larimar Therapeutics Director! - TipRanks
Larimar therapeutics: Deerfield funds buy $10.8m in shares By Investing.com - Investing.com Canada
Larimar Therapeutics stock price target lowered to $10 at Jones Trading - Investing.com Canada
Why is Larimar Therapeutics Inc. stock attracting strong analyst attentionCapitalize on high-growth stocks early - Jammu Links News
What analysts say about Larimar Therapeutics Inc. stockCapitalize on high-yield stocks early - Jammu Links News
What institutional investors are buying Larimar Therapeutics Inc. stockAchieve exceptional returns with expert guidance - Jammu Links News
What catalysts could drive Larimar Therapeutics Inc. stock higher in 2025Build wealth steadily with expert advice - Jammu Links News
How does Larimar Therapeutics Inc. compare to its industry peersBuild a portfolio that withstands market volatility - Jammu Links News
What are analysts’ price targets for Larimar Therapeutics Inc. in the next 12 monthsUnmatched profit potential - Jammu Links News
Should I hold or sell Larimar Therapeutics Inc. stock in 2025Discover stocks with strong growth potential - Jammu Links News
Is Larimar Therapeutics Inc. a good long term investmentCapitalize on market shifts before others do - Jammu Links News
What are the technical indicators suggesting about Larimar Therapeutics Inc.Unlock powerful market insights for success - Jammu Links News
What are Larimar Therapeutics Inc. company’s key revenue driversDiscover breakthrough stocks before the crowd - Jammu Links News
Larimar Therapeutics Inc expected to post a loss of 48 cents a shareEarnings Preview - TradingView
Larimar Therapeutics raises $69 million in public offering - Investing.com
Larimar Therapeutics raises $69 million in public offering By Investing.com - Investing.com Nigeria
Larimar Therapeutics Announces $64.4 Million Stock Offering - The Globe and Mail
Why Larimar Therapeutics Inc. is moving todayAutomated AI Forecast with Trading Alerts - Newser
Relative strength of Larimar Therapeutics Inc. in sector analysisSmart Trade Mapping with Entry Details - Newser
Analyzing recovery setups for Larimar Therapeutics Inc. investorsOversold Reversal Picks with Buy Zone - Newser
Larimar Therapeutics Raises $64.4 Million in Stock Offering - AInvest
0.41%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):